Skip to main content

Drug-Related Side Effects and Adverse Reactions

2
Pipeline Programs
5
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

ViiV Healthcare
ViiV HealthcareNC - Durham
1 program
1
89Zr-GSK3128349 1 mgPhase 1
AstraZeneca
AstraZenecaCAMBRIDGE, United Kingdom
1 program
1
Albuterol SulfatePhase 11 trial
Active Trials
NCT03098680Terminated18Est. Feb 2020
Cipherome
CipheromeCA - San Jose
1 program
Association Between Genetic Variant Scores and DOACs (DARES2)N/A1 trial
Active Trials
NCT04597593Completed200Est. Dec 2022
GSK
GSKLONDON, United Kingdom
1 program
89Zr-GSK3128349 1 mgPHASE_11 trial
Active Trials
NCT02829307Completed8Est. Jan 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AstraZenecaAlbuterol Sulfate
GSK89Zr-GSK3128349 1 mg
CipheromeAssociation Between Genetic Variant Scores and DOACs (DARES2)

Clinical Trials (3)

Total enrollment: 226 patients across 3 trials

NCT03098680AstraZenecaAlbuterol Sulfate

A Study of the Pharmacokinetic and Pharmacodynamic Responses in Healthy and Altered Human Cardiovascular Systems

Start: Apr 2017Est. completion: Feb 202018 patients
Phase 1Terminated
NCT02829307GSK89Zr-GSK3128349 1 mg

A Positron Emission Tomography (PET) Imaging Study to Investigate the Biodistribution and Clearance of an Albumin Binding Domain Antibody (AlbudAb) GSK3128349 in Healthy Male Subjects

Start: Aug 2016Est. completion: Jan 20178 patients
Phase 1Completed
NCT04597593CipheromeAssociation Between Genetic Variant Scores and DOACs (DARES2)

Association Between Genetic Variant Scores and DOACs (DARES2)

Start: Oct 2020Est. completion: Dec 2022200 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.